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Service delivery in older patients with bipolar
disorder: a review and development of a
medical care model
Background
Bipolar disorder is one of the worlds ten most
disabling conditions (1) and is associated with
substantial functional limitation, premature mor-
tality, and significant personal and societal costs
(2–5). Up to 40–70% of these costs have been
attributed to co-occurring general medical condi-
tions (4–7).
There has been an increased awareness of the
burden of general medical comorbidity in patients
with bipolar disorder, especially among older
patients with this illness (8–14). Cardiovascular
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Objectives: Medical comorbidities, especially cardiovascular disease
(CVD), occur disproportionately in older patients with bipolar disorder.
We describe the development, implementation, and feasibility ⁄
tolerability results of a manual-based medical care model (BCM)
designed to improve medical outcomes in older patients with bipolar
disorder.
Methods: The BCM consisted of (i) self-management sessions focused
on bipolar disorder symptom control, healthy habits, and provider
engagement, (ii) telephone care management to coordinate care and
reinforce self-management goals, and (iii) guideline dissemination
focused on medical issues in bipolar disorder. Older patients with bipolar
disorder and a CVD-related risk factor (n = 58) were consented,
enrolled, and randomized to receive BCM or usual care.
Results: Baseline assessment (mean age = 55, 9% female, 9% African
American) revealed a vulnerable population: 21% were substance users,
31% relied on public transportation, and 22% reported problems
accessing medical care. Evaluation of BCM feasibility revealed high
overall patient satisfaction with the intervention, high fidelity (e.g.,
majority of self-management sessions and follow-up contacts
completed), and good tolerability (dropout rate <5%). Use of telephone
contacts may have mitigated barriers to medical care (e.g.,
transportation).
Conclusions: The BCM is a feasible model for older, medically ill
patients with bipolar disorder, and could be an alternative to more costly
treatment models that involve co-location and ⁄or additional hiring of
medical providers in mental health clinics. Future research directions
pertinent to the development of the BCM and other medical care models
for older patients with bipolar disorder include assessment of their
long-term effects on physical health and their cost-effectiveness across
different treatment settings.
Amy M Kilbournea,b, Edward P
Posta,c, Agnes Nossekd, Elif Soneld,
Larry J Drilld, Susan Cooleyd and
Mark S Bauere
aVA Ann Arbor National Serious Mental Illness
Treatment Research and Evaluation Center,
bDepartment of Psychiatry, cDepartment of
Medicine, University of Michigan School of
Medicine, Ann Arbor, MI, dVA Pittsburgh
Healthcare System, Pittsburgh, PA, eVA Brockton
Medical Center, Brockton, MA, USA
Key words: bipolar disorder – medical
comorbidity – randomized controlled trial
Received 26 May 2007, revised and accepted for
publication 25 October 2007
Corresponding author: Amy M Kilbourne, PhD,
MPH, VA Ann Arbor SMITREC (11H), 2215 Fuller
Road, Ann Arbor, MI 48105, USA.
Fax: 734 761 2617;
e-mail: amykilbo@umich.edu
The authors of this manuscript warrant that they have no actual or
perceived conflicts of interest, financial or non-financial, in the pro-
cedures described in this manuscript.
Bipolar Disorders 2008: 10: 672–683
Copyright ª Blackwell Munksgaard 2008
BIPOLAR DISORDERS
672
disease (CVD) is the leading cause of morbidity
and mortality among older patients with bipolar
disorder (12, 13). Some of the most common
medical conditions (diabetes, hypertension, hyper-
lipidemia, and obesity) observed in older patients
with bipolar disorder are also the leading risk
factors for CVD (14), and often occur at a younger
age among patients with bipolar disorder com-
pared to those without bipolar disorder (8, 9).
Nonetheless, compared to those without bipolar
disorder, patients with this illness are less likely to
receive adequate care for CVD-related conditions
(15–18). Only half receive adequate CVD risk
monitoring related to atypical antipsychotic use
(e.g., cholesterol screening) (17), and a substantial
proportion have reported barriers to medical care
(18).
Hence, interventions that improve quality of
medical care for older persons with bipolar disor-
der are sorely needed. This paper describes the
development and implementation of a medical
treatment model for patients with bipolar disorder,
the Bipolar Disorder Medical Care Model (BCM).
We discuss the need for a new treatment approach
for older patients with bipolar and medical disor-
ders, how the BCM evolved from previously
developed treatment models, the development of
the BCM, and key issues regarding its implemen-
tation.
A bipolar medical treatment model is needed
Older patients with bipolar disorder are more
prone to the adverse effects of medical comorbidity
than their younger counterparts because of aging
combined with the cumulative burden of mania
and depression over the life span and use of
multiple medications (19–21). These characteristics
can contribute to poor adherence and unstable
treatment course, ultimately resulting in sub-
optimal outcomes (19, 20). The use of atypical
antipsychotic medications as mood stabilizers has
also increased the risk of diabetes and subsequent
CVD in older patients with bipolar disorder (21),
and the adverse effects of these medications will
become more apparent as the U.S. population
ages. Furthermore, unlike other mental disorders,
the alternating manic and depressive symptoms
associated with bipolar disorder can lead to long
periods when the patient has little or no contact
with friends or providers (e.g., during a manic
episode). Manic episodes may also be associated
with binge eating and nonadherence, while depres-
sive episodes can be associated with sedentary
lifestyle (8, 19, 20), all of which can increase the
risk of CVD and other medical conditions.
The fragmentation of mental health and general
medical care is another substantial barrier faced by
older patients with bipolar disorder. Bipolar dis-
order is primarily managed in the mental health
setting (22), and as the primary focal point of their
care revolves around the mental disorder, other
conditions are given less attention (23). Among
older patients in particular, medical conditions
may also be missed because they often present with
milder physical symptoms than in younger indi-
viduals and older patients may fail to recall
medical symptoms or conditions, or their medical
illnesses may be overlooked (23). Many of these
patients have health care needs that span several
locations (e.g., medicine, rehabilitation), and they
often have trouble accessing medical care at a
different location due to functional limitations and
transportation barriers (e.g., reliance on public
transportation) (24, 25).
Evolution of medical treatment models
Few treatment models have been developed to
address gaps in quality and outcomes of medical
care for individuals with mental disorders, and none
has been developed for bipolar disorder. Early
treatment models designed to improve medical
outcomes for patients with mental disorders
involved enhancing access through co-location of
general medical clinicians within mental health
facilities (26) or establishment of treatment teams
(27). However, these approaches may be too costly
for smaller sites to implement and sustain over time.
Alternatively, manual-based treatment models,
such as the Chronic Care Model (CCM) (28), that
focus on enhancing existing services within a
treatment setting have been shown to improve
management of chronic medical illness in primary
care patients (29, 30) and depression in older
primary care patients (31). The CCM promotes
coordination of care across different providers via a
care manager, patient self-management education,
and guideline implementation. This multifaceted
approach is necessary for improving quality and
outcomes because guideline dissemination alone is
ineffective in improving quality and outcomes of
care (30). Moreover, patient-focused behavioral
interventions that constitute self-management
approaches are most likely sustainable if coupled
with ongoing care management (30, 31). Care
managers, who are usually nurses or social workers,
can also assist older patients in navigating across
multiple (i.e., medical and psychiatric) providers.
However, no published CCM-based models exist
to manage general medical conditions (e.g., CVD)
in older patients with bipolar or other mental
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disorders. The Bipolar Collaborative Chronic Care
Model was recently developed based on the CCM
to improve mental health outcomes in patients with
bipolar disorder (32–34). However, this model was
not designed to address medical issues, as no link-
ages were established with medical care providers.
Methods
The BCM was adapted from the Bipolar Disorder
Collaborative Chronic Care Model developed by
Bauer et al. (32, 33) and Simon et al. (34) to
emphasize behavioral change and facilitated med-
ical care access for reducing the risk of CVD in
patients with bipolar disorder. The BCM interven-
tion study was developed in late 2005 and imple-
mented beginning March 2006. The BCM included
three components: patient self-management sup-
port, care management, and guideline dissemina-
tion focused on medical treatment in bipolar
disorder (Table 1). The overarching premise of
these BCM components is that optimal health
outcomes and CVD risk reduction cannot be
achieved without effective strategies for controlling
symptoms (e.g., manic, depressive), and that effec-
tive symptom control is essential for maximizing
treatment adherence and health behavior change
(e.g., improving diet, exercise). In addition, symp-
tom control is maintained through patient self-
management education combined with ongoing,
anticipatory support through care management.
BCM intervention components
Each BCM component is described briefly below.
Further details regarding the BCM components
are available from the authors.
Self-management. The BCM self-management
program was adapted from the Life Goals Pro-
gram, a group-based psychoeducational program
for bipolar disorder (35). Additional material
added to the program included CVD risk in the
context of bipolar disorder (36), strategies for
improving diet and exercise habits (37), and tips for
engaging general medical providers for older
and ⁄or medically ill patients. The self-management
program included four two-hour sessions led by
the study care manager (Table 2). Sessions were
held on a weekly basis and patients were given
workbooks with additional information covered in
the sessions. While self-management sessions were
delivered in group sessions, patients were allowed
to make up sessions over the phone as long as they
attended at least one of the sessions in person.
Care management. The care management compo-
nent was implemented at the completion of the
Table 1. Synopsis of the Bipolar Disorder Medical Care Model (BCM) intervention and comparison to usual care
Domain BCM intervention Enhanced usual care for bipolar disorder
Self-management Psychoeducation: self-management behavioral
education (group sessions on coping strategies
for symptoms, adherence, diet and exercise,
building self-efficacy via active discussions of
coping strategies) based on the Life Goals
Program
Current care under patients mental health and
general medical providers (no formal program)
Care management Nurse care manager (CM):
Scheduled contacts with patient that foster lessons
from self-management sessions, address
symptoms and side effects and facilitate provider
communication
Directly contact medical ⁄ mental health ⁄ geriatric
providers regarding urgent health concerns
based on patient communication or medical
record information
CM outreach ⁄ crisis management after critical
service encounters or missed appointments
Typical access ⁄ continuity (no CM):
Scheduled care with providers
No formal care management program
Guidelines Continuing medical education (CME) sessions and
materials addressing cardiovascular disease
(CVD) risk in older patients with bipolar disorder
and management based on guidelines from the
American Diabetes Association and guidelines for
managing bipolar disorder from the American
Psychiatric Association
CME sessions and materials addressing CVD risk
in older patients with bipolar disorder and




self-management program, and was based on
approaches to chronic care management outlined
in the Chronic Care Model. Specifically, a nurse
care manager served as a liaison between patients
and providers regarding ongoing care and encour-
aged adherence to patient self-management goals
for up to six months. Through regular phone
calls, the care manager addressed patients health
concerns, referred urgent matters to medical and
mental health providers, and promoted lessons
learned from the self-management sessions. Care
management also involved documenting patient
progress over time, and outreach ⁄ crisis manage-
ment after critical service encounters or missed
appointments.
Guideline implementation. A series of one-hour
continuing medical education (CME) in-services
were held that addressed CVD risk in older
patients with bipolar disorder for all primary
care and mental health providers. Sessions were
based on the American Diabetes Association (38)
and American Heart Association guidelines for
managing diabetes and CVD risk factors (36), and
managing psychotropic drug toxicity effects in
older patients with bipolar disorder based on
American Psychiatric Association guidelines (39).
Pocket cards summarizing these recommendations
for metabolic syndrome risk monitoring, psycho-
tropic drug toxicity monitoring, and reminders to
promote diet and exercise with patients were also
handed out as part of the educational sessions
(Table 3).
Usual care. Patients assigned to the usual-care
arm continued to receive their care through their
usual providers but did not receive the BCM
self-management program or care management
(Table 1). However, both the intervention and
usual-care providers received the guidelines. No
monitoring of usual care occurred in order to avoid
the Hawthorne effect; however, we collected infor-
mation from patient chart reviews on utilization in
order to monitor potential contamination (if any)
across treatment arms.
Model fidelity. Fidelity to the intervention was
promoted using an effectiveness-oriented approach.
That is, instead of tightly controlled treatment team
meetings that are infeasible in routine care settings,
we used the following techniques to maintain and
monitor fidelity to the BCM without burdening
staff. First, the care manager was trained by study
staff over a three-day period in August 2005.
Second, we implemented fidelity measures based
on data from care manager logs and chart review,
Table 2. Self-management sessions based on the Life Goals Program modified to address medical care and cardiovascular disease (CVD) risk
Session Topics of Life Goals session Added topics for current intervention
Session 1: Orientation Therapeutic relationship
Bipolar symptoms and psychosis
Causes of bipolar disorder, prevalence, stigma,
substance use
Causes of CVD and diabetes, risk factors among
patients with bipolar disorder
Bipolar symptoms—impact on functioning in older
patients
Introduce tips to promote healthy habits (sleep,
diet, exercise) for older patients
Session 2: Mania Recognizing manic symptoms
Personal manic symptom profile
Identify triggers of mania (e.g., substance use)
Cost-benefits of coping strategies
Medical consequences of mania
Behavioral consequences of manic symptoms
related to CVD risk (e.g., binge eating)
Coping with manic symptoms in the context of CVD
risk
Setting diet and exercise goals
Session 3: Depression Recognizing depressive symptoms
Personal depressive symptom profile
Identify triggers of depression
Cost-benefits of coping strategies
Substance abuse, suicide risk
Medical consequences of depression
Behavioral consequences of depressive
symptoms (overeating, sedentary lifestyle)
Coping with depressive symptoms in the context of
CVD risk
Maintaining diet ⁄ exercise goals: exercise











Common treatments for CVD-related conditions
Provider engagement: facilitating communication
with general medical providers (e.g., setting
goals for blood pressure, cholesterol, etc., listing
concerns, side effects)
Adherence guides (reminders)
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including number of self-management sessions
completed, number of calls, and degree to which
the registry was completed for each encounter.
Pilot study setting
We chose to adapt and test the BCM within
Veterans Affairs (VA) because it serves a dispro-
portionate number of older patients compared to
the general population, with the majority experi-
encing co-occurring conditions that often exclude
them from participating in clinical trials (39).
Although still serving a predominantly white male
population, the VA also serves increasing num-
bers of minority and female individuals, notably
with the number of women veterans now exceed-
ing 1.6 million (>6%) (24, 25). Given that the
VA patient population is on average 10 years
older than the general population, this patient
population may reflect the U.S. general popula-
tion of the future.
The VA can also inform the implementation of
integrated caremodels such as the BCMbecause the
organizational barriers to integrated care observed
in the VA (e.g., administrative, professional sepa-
ration) can also exist outside this system (40). Not
all VAmental health clinics provide general medical
services, and many patients with serious mental
illness still live a considerable distance away from
specialty mental health services (41).
Intervention design, selection, and eligibility criteria
We conducted a prospective, randomized, single-
site, single-blind intervention pilot study at a large
VA mental health facility in Pittsburgh, PA, USA,
to determine if BCM, compared to usual care,
improved quality and outcomes related to general
Table 3. Guideline implementation: provider pocket card
FRONT SIDE
Bipolar disorder: common medications, follow-up tests
Medication Common side effects Labs (at least every 6 months)
Lithium Diarrhea, vomiting, nausea, tremor, weight gain,
polyuria, acne ⁄ psoriasis and thyroid dysfunction.
RARE: kidney failure
• Electrolytes: CBC, differential,
EKG (>40 years or cardiac risk), urinalysis,
bun, creatinine




Divalproex ⁄ valproic acid Nausea, diarrhea, sedation, alopecia, LFT elevation.
RARE: liver failure, pancreatitis
CBC and LFT, lipase, pregnancy test,
divalproex level
Carbamazepine Nausea, dizziness, rash, blurred vision, ataxia Carbamazepine level, CBC, liver profile
Lamotrigine Headache, ataxia, nausea, insomnia, tremor Pregnancy test
Risperidone Akathisia, orthostatic hypotension, agitation Pregnancy test. Also see reverse side
Quetiapine Weight gain, headache, drowsiness, dizziness Pregnancy test, ophthalmic exam (slit lamp)
BACK SIDE
Bipolar disorder treatment: risk of metabolic syndrome
Atypical antipsychotics: Follow-up care
• Height, weight (BMI) waist circumference:





• Additional tests if CVD: EKG, electrolytes (Ca and Mg), Holter, if indicated
• Counsel on diet, exercise:
Reduce fat, sugar intake; physical activity, smoking cessation
Risks: weight gain, hyperglycemia, dyslipidemia
Greatest risks: Clozapine, Olanzapine
Lesser risks: Quetiapine, Risperidone
Lowest risks: Ziprasidone, Aripiprazole
Baseline case
• Height, weight (BMI) and waist circumference






Improving Care for Veterans with Bipolar Study (care manager contact information)
CBC = complete blood cell count; EKG = electrocardiogram; LFT = liver function test; TSH = thyroid stimulating hormone; BMI = body
mass index; CVD = cardiovascular disease; DM = diabetes mellitus; HTN = hypertension; Ca = calcium; Mg = magnesium.
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medical care for patients with bipolar disorder.
This facility serves as the primary source of mental
health care for the vast majority of veterans in
the Western Pennsylvania region. The nearest VA
general medical clinic is located at a facility that is
approximately seven miles from the mental health
clinic.
Patient inclusion criteria were: (i) adult patients
in the Continuous Improvement for Veterans in
Care–Mood Disorders cohort who had an active
diagnosis or treatment plan for bipolar disorder
[I, II, or not otherwise specified (NOS)] from a
clinician; (ii) assigned a primary care provider in
the VA; and (iii) diagnosis of or receiving treat-
ment for at least one of the following medical
conditions most strongly related to CVD risk:
hypertension, hyperlipidemia, diabetes mellitus, or
obesity [or body mass index (BMI) >25]. We chose
to include patients with bipolar II disorder or
bipolar disorder NOS because of evidence suggest-
ing that these patients experience a similar level of
functional decline and medical comorbidity com-
pared to those with bipolar I disorder (11).
Patients were excluded if they (i) had unresolved
substance intoxication or withdrawal, such as
appearing to be intoxicated (e.g., incoherent,
slurred speech); (ii) were already enrolled in a
mental health program with a mobile outreach
component in which clinical caregivers deliver
services to the patient in the community (e.g.,
assertive community treatment or intensive case
management); or (iii) were unwilling or unable to
provide informed consent or comply with study
requirements at the time of enrollment. Eligible
patients were consented, enrolled, and randomized
to receive either the BCM or enhanced usual VA
care (guideline implementation only).
Eligible patients were then randomly selected by
the data analyst and contacted via telephone by a
survey coordinator, and completed a baseline
assessment over the phone and subsequent assess-
ments at three and six months. Enrolled patients
were then randomized by the study data analyst to
receive the BCM or usual care. This randomized
controlled trial was reviewed and approved by
local institutional review boards.
Assessments and selection of outcomes
Assessments were completed over the phone by a
survey coordinator who was blinded to randomi-
zation assignment. These 30-minute assessments
included questions on key outcomes and other
patient factors, including demographics, behaviors,
and treatment perspectives. Additional informa-
tion on utilization, comorbidities, lab values rep-
resenting CVD risk factors, and other clinical
variables was collected from a chart review con-
ducted by the survey coordinator at baseline and
six months.
Our primary outcomes included physical and
mental health-related quality of life, and secondary
outcomes included global functioning and bipolar
disorder symptoms. Health-related quality of life
was assessed using the 12-item Short Form Health
Survey (SF-12), which generates a physical and
mental health summary score (range: 0–100) (42).
TheSF-12was found tobehighly correlatedwith the
SF-36 on the mental health (r = 0.91) and physical
health (r = 0.92) summary scores (42). Global
functioning was measured using the World Health
Organization Disability Assessment Scale (WHO-
DAS) (43), a 12-item assessment of the degree of
functional impairment experienced within the past
month regarding self-care (e.g., bathing, dressing),
mobility (e.g., standing, walking), cognition (e.g.,
remembering), social functioning (e.g., conversing),
and role functioning. Bipolar disorder symptoms
were assessed using the Internal State Scale (ISS), a
15-item self-completed instrument that generates
subscales reflecting depressive, manic, or euthymic
symptoms. The ISS has high test-retest reliability,
and the symptom subscales are highly correlated
with clinician ratings of current episode (44).
We also assessed patient demographics, socio-
economic status, support, and health behaviors
(substance use and adherence), and treatment
characteristics thought to potentially influence the
effect of the BCM on outcomes. Alcohol use was
measured using one question that reflects hazard-
ous, or binge drinking (defined as five or more
drinks on a single occasion) from the Alcohol Use
Disorders Identification Test (45). Illicit drug use
and smoking were assessed using the Composite
International Diagnostic Interview Survey short
form survey (46). Adherence was assessed based on
the number of missed doses within the past week,
which was strongly correlated with other valid
measures of adherence (e.g., electronic monitoring)
(47).
Treatment characteristics such as access to
medical care and self-efficacy in managing chronic
illness were also included in the patient survey. We
included questions from the Cunningham Access
to Care Survey (48), which asks about perceived
barriers to needed medical care using a five-point
Likert scale. Patients also completed a survey on
perceived self-efficacy in self-managing chronic
illness developed by Lorig et al. (49). Other treat-
ment characteristics such as current medications
were collected from medical records using a stand-
ardized chart review form.
Bipolar disorder care model
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Evaluation
This paper reports on the baseline characteristics of
the study sample (demographics, behaviors, and
baselineoutcome scores), fidelity, feasibility ⁄accept-
ance, and overall implementation. Descriptive sta-
tistics were used to assess baseline characteristics of
the study population, describe the distribution of
ourmain outcome (quality of life asmeasured by the
SF-12 physical and mental health component
scores), fidelity to the treatment model, and overall
satisfactionwith the self-management program.Our
fidelity measures included number of self-manage-
ment sessions offered by the care manager and
attended by patients, number of calls made by the
care manager and those completed by the patient,
and the number of completed registry entries on
each patient. We also evaluated the models feasi-
bility and acceptance (participant satisfaction). We
also analyzed the BCMs implementation by review-
ing care manager contacts, and estimated the total
time the care manager spent on the BCM.
Results
Sample characteristics and retention (tolerability)
Between March and June 2006, 79 patients were
confirmed to be eligible for the BCM study. Of the
79, 61 were randomly selected to be contacted for
participation. Of the 61, three were lost to follow-
up (4.9% dropout), leaving 58 patients who
completed baseline and follow-up surveys.
Patient baseline characteristics are presented in
Table 4. The mean age was 55.3 years (SD = 8.4;
range: 30–73), and 29% (n = 17) were 60 years of
age or older. Overall, 8.6% (n = 5) were female,
and 8.6% (n = 5) non-white (African American).
The demographics of our patients were similar to
the demographic characteristics of all VA patients
diagnosed with bipolar disorder based on the VA
National Psychosis Registry (i.e., mean age = 52
years, 13% women, 9% African American) (34). In
addition, 39.7% (n = 23) lived alone and 31.0%
(n = 18) relied on a VA van or public transpor-
tation to get to appointments.
Most patients (76.8%, n = 44) were diagnosed
with bipolar I disorder and 41% (n = 24) were
prescribed atypical antipsychotic medications. The
majority (80%, n = 47) were diagnosed with
hypertension, 75% (n = 44), with hyperlipidemia,
and 32% (n = 19) with diabetes; 88% (n = 52)
were overweight (BMI>25) and 19% (n = 11)
were diagnosed with coronary artery disease. In
addition, 90% (n = 52) were diagnosed with two
or more CVD-related conditions. Almost a quarter
(20.7%, n = 12) reported current alcohol use
(binge drinking) or illicit drug use at the time of
enrollment. Almost a quarter reported some trou-
ble accessing medical care.
Mean overall physical and mental health-related
quality of life (SF-12) scores at baseline were,
respectively, 36.6 (SD = 7.6) and 33.1 (SD = 7.1).
In contrast, mean SF-12 physical and mental
health summary scores are 50 (SD = 10) for the
U.S. general population.
Model fidelity
The mean number of completed self-management
sessions (group or phone) was 3.7 out of 4
(SD = 0.7; range: 2–4). The mean number of group
sessions completed in person was 1.8 (SD = 1.8;
range: 1–4 sessions) and themean number of phone-
only sessions was 1.9 (SD = 1.6; range: 0–3 ses-
sions). The primary reason reported for missing
group sessions was lack of transportation. One
patient did not attend remaining group sessions
because he felt anxious in public settings. The mean
number of post-group completed care management
calls over the three-month period was 6.6 (SD =
2.8; range: 0–11 calls) and the mean number of
attempted or completed calls was 10.6 (SD = 4.8;
range: 3–18 calls). Most (95%) of these calls were
recorded in the registry, and 85% of registry entries
were completed by the care manager.
Satisfaction
We rated the overall satisfaction with the self-
management program among the first 12 enrollees
using an anonymous survey. Out of 12, nine
returned the surveys. Of the nine, five (56%) rated
the program (all four sessions) as excellent and
four (44%) rated it as very good. The most
common topics that they found helpful included
coping with symptoms and making a plan for their
medical provider. What respondents liked most
included the opportunity to talk, the focus on
bipolar disorder, and the workbook. Suggested
improvements included providing more details
regarding the specific medications for bipolar
disorder (Table 5). At least two patients expressed
to the care manager that they were using the self-
management program as a new starting point to
help them maintain a new job after being out of
work for several months due to bipolar disorder.
Implementation
Based on a review of completed call summaries
from the file registry, we found a wide variation in
Kilbourne et al.
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patient clinical issues that were addressed by the
care manager. For example, one patient expressed
concerns regarding medication side effects. After
discussing these concerns with the care manager,
the care manager relayed the patients information
to his mental health provider, who promptly
scheduled a follow-up appointment. In another
instance, the patient failed to show up for an
appointment because of fatigue. The care manager
prompted the health care provider to follow up
with this patient to determine the cause of the
fatigue. Additional issues covered in the calls
included cutting down on alcohol use, grief regard-
ing the loss of a loved one, encouraging exercise to
relieve stress, encouraging the patient to obtain a
fasting lipid panel, and physical symptoms (e.g.,
anemia). In all cases in which the care manager
followed up with the patients provider regarding
urgent matters, the provider was able to see the
patient or get back to him or her within a few days.
We also found that the care manager collected
information from patients not available from the






(n = 31) F (df) p-value
Demographics
Age (range: 30–73), mean (SD) 55.3 (8.4) 54.5 (8.7) 56.0 (8.2) 0.46 (57) 0.50
n (%) n (%) n (%) v2 (df) p-value
Age breakdown
<50 years 9 (15.5) 4 (14.8) 5 (16.1) 0.27 0.60
50–59 years 32 (55.2) 16 (59.2) 16 (51.6)
‡60 years 17 (29.3) 7 (26.0) 10 (32.3)
Female 5 (8.6) 2 (7.4) 3 (9.7) 0.09 (1) 0.76
Non-white 5 (8.6) 2 (7.4) 4 (12.9) 1.52 (1) 0.29
Education: some college 15 (26.3) 7 (25.9) 8 (25.8) 0.00 (1) 0.99
Married ⁄ cohabitating 22 (37.5) 9 (33.3) 13 (41.9) 0.45 (1) 0.50
Lives alone 23 (39.7) 11 (40.7) 12 (38.7) 0.02 (1) 0.87
Takes van or bus to mental health appointments 18 (31.0) 6 (22.2) 12 (38.7) 1.83 (1) 0.18
Current substance use 12 (20.7) 7 (25.9) 5 (16.1) 0.84 (1) 0.36
Tobacco use 29 (50.0) 14 (51.9) 15 (48.4) 0.07 (1) 0.79
Trouble accessing medical carea 13 (22.4) 5 (18.5) 8 (25.8) 0.44 (1) 0.51
Bipolar disorder diagnosis
Bipolar I 44 (76.8) 21 (80.8) 22 (73.3) 2.75 (2) 0.25
Bipolar II 4 (5.4) 0 (0.0) 3 (10.0)
Bipolar NOS 10 (17.8) 5 (19.2) 5 (16.7)
Current CVD-related diagnoses
Hypertension 47 (79.7) 21 (77.8) 26 (83.9) 0.35 (1) 0.55
Hyperlipidemia 44 (74.6) 22 (81.5) 22 (71.0) 0.87 (1) 0.35
Diabetes 19 (32.2) 8 (29.6) 11 (35.5) 0.22 (1) 0.63
Obesity or BMI >25 52 (88.1) 23 (85.2) 29 (93.6) 1.08 (1) 0.30
Coronary artery disease 11 (19.0) 3 (11.1) 8 (25.8) 2.03 (1) 0.15
Any atypical antipsychotic use 24 (40.7) 10 (37.0) 14 (45.2) 0.39 (1) 0.53
Outcomes at baseline Mean (SD) Mean (SD) Mean (SD)
SF-12
Physical health 36.6 (7.6) 37.2 (7.4) 36.2 (7.9) 0.24 (57) 0.63
Mental health 33.1 (7.1) 33.2 (6.6) 33.0 (7.5) 0.01 (57) 0.91
Global functioning (WHO-DAS)b 17.9 (9.9) 17.0 (10.1) 18.6 (9.7) 0.42 (57) 0.52
Bipolar symptomsc
Well-being 14.6 (7.9) 14.8 (8.1) 14.5 (7.8) 0.03 (57) 0.86
Depressive 7.9 (6.1) 7.1 (6.3) 8.6 (5.9) 0.88 (57) 0.35
Manic 19.2 (12.6) 19.4 (17.5) 18.9 (13.5) 0.03 (57) 0.87
BCM = Bipolar Disorder Medical Care Model; NOS = not otherwise specified; CVD=cardiovascular disease; BMI = body mass index;
SF-12 = 12-item Short Form Health Survey; WHO-DAS = World Health Organization Disability Assessment Scale.
aBased on a response of strongly disagree or disagree compared to uncertain, agree, or strongly agree to the statement: I am able
to get medical care whenever I need it.
b0–48 points; higher score indicates worse functioning.
cSymptom scores based on the Internal States Scale. Total scores were generated for depressive (0–20 points), manic (0–50 points),
and euthymic symptoms (0–30 points). For depressive and manic symptoms, lower is better. For euthymic symptoms (well-being),
higher is better.
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electronic medical record, including symptoms,
moods, and disposition (e.g., current job or home).
The care manager primarily relied on this informa-
tion to monitor patient progress and track commu-
nication with providers rather than the electronic
medical record, which was seen as information
overload. The VA electronic medical record was
used primarily to record each session or phone call
in order to count these encounters as visits.
Finally, we estimated the total time the care
manager spent on the BCM. The care manager
recorded the total amount of time spent on each
patient over the three-month period, including
group sessions, call attempts, calls, and charting
(e.g., in the electronic medical record and registry)
by recording this information on a continued basis
for each patient encounter using the registry. We
then totaled up the number of hours spent per
patient and multiplied this number by four to
reflect an annualized estimate. Overall, the care
manager was estimated to spend an average 32 h
on each patient per year, in which 20.5 h were
spent on the phone care management, 4.9 h per
patient on the self-management program, and
6.6 h documenting and charting.
Discussion
Our baseline results indicate that this randomized
controlled trial of the BCM enrolled a vulnerable
patient population. A disproportionate number of
individuals live alone, rely on public transporta-
tion, report substance use, and report some prob-
lem accessing medical care. Baseline health-related
quality of life scores were lower than national
norms. It is noteworthy that many of these patients
may not have been enrolled in more tightly
controlled efficacy studies, which often directly
exclude patients based on medical or substance use
comorbidities, or indirectly exclude them through
intensive treatment models (e.g., multiple visits and
assessments requiring transportation to and from
the clinic).
Despite the fact that we enrolled a more vulner-
able patient population, our retention, fidelity, and
evaluation results suggest that the BCM was
successfully implemented. Dropout rates were
small (<5%) and fidelity to the BCM was on par
with previous CCM-based models (80%) (33). In
fact, in clinical trials, the rate of treatment adher-
ence can range from 43–78% (50). We were able to
improve model fidelity in our study by offering
make-up self-management sessions over the tele-
phone to individuals who did not complete all
sessions in person. While the telephone sessions did
not include the group interactions that are crucial
for helping patients discuss bipolar disorder
management strategies, such contacts nonetheless
provided comparable information, encouragement,
and tips regarding symptom control, lifestyle
changes, and provider engagement.
Table 5. Results from the self-management program satisfaction survey
(n = 9)
Things learned
Understand reactions to life
People let me talk
People gave me feedback
Make a plan before going to my general medical provider
Talk things out with MD




Beware of episodes and triggers
Bipolar is a disease, not a character defect
Bipolar disorder is not necessarily a barrier to excellent
achievement
I have value as an individual person
Have manual to refer to – wallet cards on mania and
depression triggers, medications (2)
Coping with mania and signs of manic, depressive symptom
(2)





Got to talk about what I was interested in, and see that how it
related to other group members (2)
Group discussion (2)
The focus on bipolar disorder
Just knowing Im not alone
Care managers understanding (2)
Like to see changed
Nothing
When meeting is opened ask everyone to say something;
then those who have more to talk about can use up the
remaining time
Missed the first session and would like to attend again at the
future session
More information on medications
Suggested future topics
Dual diagnosis
Side effects of different meds
Posttraumatic stress disorder
Medications in more detail
Cant think of anything at this point
Other comments
Workbook is the best tool Ive received from the VA since
starting in 1991
Of my rapid cycling bipolar psychosis—picked up a number
of key points that can be put away to use that will help me
stay out of the hospital
Im always looking for signs of highs (manic) which happen to
me, that I let them go too far. I begin to lose touch with the
real world
Things that arent real take me past the point that get me in




Most patients surveyed were satisfied with
the self-management program, and it may have
satisfied an unmet need for psychoeducation and
promotion of healthy habits tailored to patients
with bipolar disorder. A review of the care man-
agement contacts also revealed that the care
manager served as an effective liaison between
patients and providers, notifying the latter about
more urgent patient concerns, which prompted the
provider to schedule a visit or call with the patient.
Hence, telephone contacts may have mitigated
transportation barriers experienced by these pa-
tients, as many relied on public transportation or
the VA van to get to appointments. The care
manager primarily relied on the registry to track
patient progress and collect information from
telephone contacts, rather than the existing VA
electronic medical record. Given that older patients
often face transportation barriers, health service
interventions should perhaps be customized to
accommodate telephone or telepsychiatry contacts.
Our preliminary data on care manager time also
suggest that the BCM can potentially benefit more
patients than existing treatment models for serious
mental illness. We estimated that the care manager
spent on average 32 hours per patient per year,
which is on par with estimates of care manager
time previously reported in prior bipolar disorder
interventions (33). This estimate results in a total
yearly caseload of about 50–60 patients for a full-
time nurse care manager, while alternative models
such as Intensive Case Management often limit
caseloads to 12 patients per case manager. This
represents an appropriate caseload, as older
patients with bipolar disorder are often too ill to
be managed through routine outpatient care, yet
are often functioning well enough not to need
intensive case management. Moreover, future
research will determine whether a BCM model
solely based on telephone management is as
effective and cost efficient as the current BCM,
which includes in-person group sessions.
The strengths of this pilot study include the use
of randomization to pilot test one of the first
models designed to improve medical care quality in
bipolar disorder, and the BCMs effectiveness-
oriented design that facilitates its implementation
in routine care practice. Still, there are limitations
to this study that warrant consideration. First, the
intervention was limited to a single VA site;
however, this site served as the catchment area
for the majority of veterans in care in the Western
Pennsylvania region. The VA population is also an
older and more indigent patient population, which
can reflect other patient populations outside the
VA (e.g., Medicaid clients). Second, the VAs
extensive electronic medical record system, which
includes medical and mental health care, may
not reflect the resources seen in typical non-VA
practices.
In light of the strengths and weaknesses of the
BCM study, there are a number of future research
directions regarding the further development and
implementation of manual-based medical treat-
ment models for older patients with bipolar disor-
der. Notably, additional studies should assess the
long-term impact of the BCM on CVD-related risk
factors such as high blood pressure and choles-
terol, and determine if manual-based models can
reduce the risk of CVD and related disorders. In
addition, future research should focus on the
implementation and dissemination of manual-
based medical care models for bipolar disorder in
community-based settings, especially those that are
not well integrated compared to the VA setting. A
number of older individuals with mental disorders
live in rural areas, and emerging technologies such
as telepsychiatry could play an important role in
improving access to medical care for this group.
Finally, an estimate of the interventions cost and
cost-effectiveness will be helpful in sustaining the
models in routine care settings once the research
project is completed.
Overall, the BCM is a promising and feasible
treatment model for sites that cannot afford
intensive treatment teams or co-locating providers
from different specialties. Our preliminary data
suggest that the BCM can be implemented in a
routine care setting that serves a vulnerable, older,
and more medically ill patient population. Ulti-
mately, the BCM can potentially benefit older
patients with bipolar disorder, who are increasingly
suffering from medical illness, through a manual-
based strategy that may ultimately improve
outcomes and overall recovery.
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